There is a "better than average chance" Edwards Lifesciences (EW +3.5%) will prevail in a German...

|About: Edwards Lifesciences Corp (EW)|By:, SA News Editor

There is a "better than average chance" Edwards Lifesciences (EW +3.5%) will prevail in a German patent infringement case against Medtronic (MDT +0.1%), Canaccord (Buy) analyst Jason Mills says, adding that an injunction against MDT's CoreValue product "could propel" EW to $85/share. Separately, Credit Suisse upgrades EW to Outperform from Neutral.